EOP2
a formal meeting between the sponsor and the FDA Review Dviision assigned to a drug project at which the data collected in Phase 2 are used to shape and agree the Phase 3 clinical studies design and any other outstanding issues that must be addressed in the NDA.
Course: REG209
